Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3

被引:87
|
作者
Firth, SM [1 ]
Baxter, RC [1 ]
机构
[1] Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia
关键词
D O I
10.1677/joe.0.1600379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Then are three potential N-glycosylation sites in the non-conserved central region of the insulin-like growth factor binding protein-3 (IGFBP-3) sequence (N(89)AS, N(109)AS, (NFS)-F-172). IGFBP-3 exists as two glyco-forms which reduce to a single form on enzymatic deglycosylation. To determine the functional significance of the carbohydrate chains, the N-glycosylation sites were mutated singly and in combinations by substituting Asn residues with Ala. Each recombinant glycoform was detected by radioimmunoassay, indicating that glycosylation is not essential for secretion in Chinese hamster ovary cells. Ligand blotting of the conditioned media using [I-125]IGF-I indicated that all seven mutants are active. On the basis of the number and molecular masses of the: bands detected for each glycoform, there is approximately 4, 4.5 and 5 kDa of carbohydrate on Asn(89), Asn(109) and Asn(172) respectively, with variable occupancy of Asn(172). Ternary complex formation by the glycovariants in the: presence of ALS and excess IGF-I was not significantly different from that of fully glycosylated recombinant human (rh)IGFBP-3 [K-a (fully glycosylated)= 12.5 +/- 4.1 l/nmol; mean K-a (all mutants) = 22.1 +/- 3.0 l/nmol]. In contrast, Asn to Asp substitutions decreased acid-labile subunit (ALS) binding activity. Cell-surface association experiments indicate that glycosylation may influence the partitioning of IGFBP-3 between the extracellular milieu and the cell surface. Therefore, while the carbohydrate units appear to be non-essential to ALS or IGF binding, they may modulate other biological activities of IGFBP-3.
引用
收藏
页码:379 / 387
页数:9
相关论文
共 50 条
  • [31] Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis
    Toussirot, E
    Nguyen, NU
    Dumoulin, G
    Regnard, J
    Wendling, D
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (11): : 1172 - 1176
  • [32] Racial and anthropometric differences in plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein-3
    McGreevy, K
    Hoel, B
    Lipsitz, S
    Bissada, N
    Hoel, D
    UROLOGY, 2005, 66 (03) : 587 - 592
  • [33] Insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in women with premenstrual syndrome
    Rapkin, AJ
    Cedars, M
    Morgan, M
    Goldman, L
    FERTILITY AND STERILITY, 1998, 70 (06) : 1077 - 1080
  • [34] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 ENHANCES INSULIN-LIKE GROWTH-FACTOR BINDING AND MITOGENESIS IN OSTEOBLAST-LIKE CELLS
    ANDRESS, DL
    LOOP, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S216 - S216
  • [35] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 CONCENTRATIONS AND INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 PROTEASE ACTIVITY IN SERA OF PATIENTS WITH MALIGNANT SOLID TUMORS OR LEUKEMIA
    MULLER, HL
    OH, Y
    GARGOSKY, SE
    WILSON, KF
    LEHRNBECHER, T
    ROSENFELD, RG
    PEDIATRIC RESEARCH, 1994, 35 (06) : 720 - 724
  • [36] Competitive binding assay for determination of rat insulin-like growth factor binding protein-3
    Frystyk, J
    Baxter, RC
    ENDOCRINOLOGY, 1998, 139 (03) : 1454 - 1457
  • [37] The effects of recombinant human insulin-like growth factor-1/insulin-like growth factor binding protein-3 administration on lipid and carbohydrate metabolism in recreational athletes
    Guha, Nishan
    Nevitt, Simon P.
    Francis, Michael
    Bohning, Walailuck
    Bohning, Dankmar
    Sonksen, Peter H.
    Holt, Richard I. G.
    CLINICAL ENDOCRINOLOGY, 2021, 94 (04) : 551 - 562
  • [38] USE OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 FOR THE EVALUATION OF GROWTH DISORDERS
    BLUM, WF
    RANKE, MB
    HORMONE RESEARCH, 1990, 33 : 31 - 37
  • [39] Insulin-like growth factor binding protein-3 generation: An index of growth hormone insensitivity
    Thalange, NKS
    Price, DA
    Gill, MS
    Whatmore, AJ
    Addison, GM
    Clayton, PE
    PEDIATRIC RESEARCH, 1996, 39 (05) : 849 - 855
  • [40] No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis
    Skjærbæk, C
    Kaal, A
    Moller, J
    Vahl, N
    Weeke, J
    Orskov, H
    Flyvbjerg, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04): : 1206 - 1210